1-6 of 6
Yolanda Fortenberry
Close
Sort by
Journal Articles

Antithrombin-Specific RNA Aptamers As a Potential Therapy to Restore Hemostatic Balance in Hemophilia Patients

Yolanda Fortenberry, Zahraa Abdulameer, Mariam Barak, Khalequz Zaman
Journal: Blood
Blood (2022) 140 (Supplement 1): 11275.
https://doi.org/10.1182/blood-2022-166896
Published: 2022
Journal Articles

Characterization of Antithrombin-Specific RNA Aptamers for Use in Anticoagulant Therapy

Yolanda Fortenberry, PhD
Journal: Blood
Blood (2014) 124 (21): 4236.
https://doi.org/10.1182/blood.V124.21.4236.4236
Published: 2014
Journal Articles

Inactivation of Plasminogen Activator Inhibitor-1 by RNA Aptamer Molecules

Yolanda Fortenberry, PhD, Jared Damare
Journal: Blood
Blood (2012) 120 (21): 1107.
https://doi.org/10.1182/blood.V120.21.1107.1107
Published: 2012
Journal Articles

Effect of PAI-1 Specific RNA Aptamers On Cell Adhesion and Motility.

Yolanda Fortenberry, PhD, Charlene M Blake, Ph.D., Bruce A Sullenger, Ph.D.
Journal: Blood
Blood (2009) 114 (22): 2135.
https://doi.org/10.1182/blood.V114.22.2135.2135
Published: 2009
Journal Articles

Inhibition of Factor VIIa-Tissue Factor by Protein C Inhibitor.

Yolanda Fortenberry, PhD, Anne B. Cook, BS, Frank C. Church, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 1743.
https://doi.org/10.1182/blood.V110.11.1743.1743
Published: 2007
Journal Articles

Regulation of Cathpsin L by the Serpin Protein C Inhibitor.

Yolanda Fortenberry, Ryan Bialas, Candace Mitchell, Frank C. Church
Journal: Blood
Blood (2006) 108 (11): 336.
https://doi.org/10.1182/blood.V108.11.336.336
Published: 2006